Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Short-term Investments (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Short-term Investments readings, the most recent being $202.0 million for Q4 2025.

  • On a quarterly basis, Short-term Investments fell 45.26% to $202.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $202.0 million, a 45.26% decrease, with the full-year FY2025 number at $202.0 million, down 45.26% from a year prior.
  • Short-term Investments hit $202.0 million in Q4 2025 for Tandem Diabetes Care, down from $227.2 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $552.6 million in Q4 2021 to a low of $202.0 million in Q4 2025.
  • Median Short-term Investments over the past 5 years was $408.9 million (2023), compared with a mean of $403.2 million.
  • Biggest five-year swings in Short-term Investments: soared 358.04% in 2021 and later tumbled 46.46% in 2025.
  • Tandem Diabetes Care's Short-term Investments stood at $552.6 million in 2021, then decreased by 19.59% to $444.4 million in 2022, then fell by 7.95% to $409.0 million in 2023, then fell by 9.77% to $369.1 million in 2024, then tumbled by 45.26% to $202.0 million in 2025.
  • The last three reported values for Short-term Investments were $202.0 million (Q4 2025), $227.2 million (Q3 2025), and $251.2 million (Q2 2025) per Business Quant data.